| Company Name: |
Cool Pharm, Ltd |
| Tel: |
021-60455363 18019463053 |
| Email: |
sales@coolpharm.com |
|
| | 5-(piperazin-1-yl)benzofuran-2-carboxylic acid Basic information |
| Product Name: | 5-(piperazin-1-yl)benzofuran-2-carboxylic acid | | Synonyms: | Vilazodone Impurity 28;2-Benzofurancarboxylic acid, 5-(1-piperazinyl)-;5-(1-piperazinyl)-2-Benzofurancarboxylic acid;5-(Piperazine-1-yl)benzofuran-2-carboxylic acid;5-(piperazin-1-yl)benzofuran-2-carboxylic acid;4-[5-(Piperazine-1-yl) benzofuran-2-carboxylic acid;5-(1-Piperazinyl)benzofuran-2-carboxylic acid;1-(2-Carboxybenzofuran-5-yl)piperazine | | CAS: | 183288-47-3 | | MF: | C13H14N2O3 | | MW: | 246.26 | | EINECS: | | | Product Categories: | Intermediates | | Mol File: | 183288-47-3.mol |  |
| | 5-(piperazin-1-yl)benzofuran-2-carboxylic acid Chemical Properties |
| Melting point | >209° C (dec.) | | density | 1.315 | | storage temp. | 2-8°C | | solubility | Acidic DMSO (Slightly) | | form | Solid | | color | Pale Brown to Light Brown |
| | 5-(piperazin-1-yl)benzofuran-2-carboxylic acid Usage And Synthesis |
| Uses | 5-(1-Piperazinyl)benzofuran-2-carboxylic Acid is an intermediate in the synthesis of Vilazodone (V265000), a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. |
| | 5-(piperazin-1-yl)benzofuran-2-carboxylic acid Preparation Products And Raw materials |
|